Literature DB >> 21323548

Clopidogrel with or without omeprazole in coronary disease.

David N Juurlink.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323548     DOI: 10.1056/NEJMc1013859

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Trends in the coprescription of proton pump inhibitors with clopidogrel: an ecological analysis.

Authors:  David N Juurlink; Tara Gomes; J Michael Paterson; Chelsea Hellings; Muhammad M Mamdani
Journal:  CMAJ Open       Date:  2015-11-26

2.  Clopidogrel and proton pump inhibitors.

Authors:  David Juurlink
Journal:  CMAJ       Date:  2014-02-18       Impact factor: 8.262

Review 3.  Thienopyridine-associated drug-drug interactions: pharmacologic mechanisms and clinical relevance.

Authors:  Jean-Sébastien Hulot; Jean-Philippe Collet; Gilles Montalescot
Journal:  Curr Cardiol Rep       Date:  2011-10       Impact factor: 2.931

4.  Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey.

Authors:  Jacek Budzyński; Grzegorz Pulkowski; Karol Suppan; Jacek Fabisiak; Marcin Majer; Maria Kłopocka; Beata Galus-Pulkowska; Marcin Wasielewski
Journal:  Health Qual Life Outcomes       Date:  2011-09-22       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.